Associate Professor Moffat is a medical imaging physicist and chemist with 19 years’ research experience in the Biomedical Imaging fields of MRI and Molecular Imaging. Since graduating from his PhD in 2001, he has made excellent and ongoing contributions to this field. He is currently deputy director of the Melbourne Brain Imaging Capability, The University of Melbourne node of the National Imaging Facility. He has specific expertise in quantitative Ultra High Field (7 Tesla) MR imaging of human subjects and Molecular Imaging biomarker research, development and clinical translation (Royal Melbourne Hospital 2007-14). He has published significant journal articles on fMRI, diffusion MRI, functional diffusion mapping, MR perfusion, MRS, voxel-based morphometry, PET and nano-theranostics.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
Rebecca V Robertson, Noemi Meylakh, Lewis S Crawford, Fernando A Tinoco Mendoza, Paul M Macey, Vaughan G Macefield, Kevin A Keay, Luke A Henderson
Read Publication
Joseph J. Bartlett, Catherine E. Davey, Leigh A. Johnston, Jinming Duan
Read Publication